Concepedia

Atorvastatin and quinapril inhibit blood coagulation in patients with coronary artery disease following 28 days of therapy

Anetta Undas, Kathleen E. Brummel‐Ziedins, Daniel P. Potaczek, Bożena Stobierska-Dzierżek, L. Bryniarski, A Szczeklik, Kenneth G. Mann

Journal of Thrombosis and Haemostasis · 2006 · 36 citations · 17 references

DOIFull text

Open access

Concepts

References

17

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

New England Journal of Medicine · 2000 · 8.7K citations · Full text

, , +16

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)

Kim Fox · The Lancet · 2003 · 2.2K citations

, , +13

Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery Disease

New England Journal of Medicine · 2004 · 1.1K citations · Full text

, , +16

Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53.

Salim Yusuf, Prabhat Jha · 2000 · 897 citations

, , +17

Blood clotting in minimally altered whole blood

MD Rand, JB Lock, Cornelis van’t Veer et al. · Blood · 1996 · 400 citations · Full text

, , +9